The Humanistic Impact of X-Linked Retinitis Pigmentosa (XLRP): Results from the Explore Xlrp-2 Retrospective Chart Review and Cross-Sectional Survey of Patients and Caregivers in 10 Countries

Author(s)

Denee T1, Lahaye M1, van Denderen J1, Lee J2, Pungor K3
1Janssen-Cilag, Breda, Netherlands, 2Janssen-Cilag A/S, Birkerod, Rudersdal, Denmark, 3Janssen-Cilag GmbH, Neuss, Germany

OBJECTIVES: To understand the relationship between the clinical stages of the rare, inherited retinal disorder X-linked retinitis pigmentosa (XLRP) associated with RPGR and the real-world humanistic impact on patients and caregivers.

METHODS: The exploratory, multicentre, non-interventional EXPLORE XLRP-2 study of patients and caregivers combined a retrospective chart review (to collect clinical/demographic data, including XLRP clinical stage [mild, moderate, severe]) with cross-sectional surveys (validated and modified patient- and caregiver-reported outcomes and a sponsor-developed questionnaire).

RESULTS: 176 patients from 10 countries (Austria, Finland, France, Germany, Ireland, Israel, Italy, the Netherlands, Spain, United Kingdom) with XLRP caused by RPGR were enrolled; 169 patients were included in the analyses (81% male; mean age: 39.3 years [SD: 17.6 years]), including 20 adolescents aged 12–17 years. Nyctalopia/night blindness (56%) was the most reported initial XLRP symptom. More severe clinical stage was significantly correlated (p0.05) with worse outcomes on most of the patient survey scores, including modified Low Luminance Questionnaire (mLLQ) subscales among adults and some mLLQ subscales among adolescents; Work Productivity & Activity Impairment (WPAI) absenteeism, presenteeism, productivity loss, and activity impairment domains; Patient Global Impression of Mobility and Daily Activity scores; Hospital Anxiety and Depression Scale (HADS) depression score; and sponsor-developed questions (e.g. greater reliance on caregiver support, impacts on career/group activities/financial situation, more healthcare visits, increased support from social services). Among caregivers (n=69; 88% female), mean hours/week spent caregiving was 29 [SD: 35]; caregivers reported high overall well-being (EQ-5D-5L, HADS, and Caregiver Well-Being Scale scores). 55% of adult patients and 72% of caregivers reported being employed.

CONCLUSIONS: This first real-world study to assess the humanistic and quality-of-life impacts of XLRP demonstrates important individual, societal, and healthcare resource use impacts, are more likely to be greater in patients with more severe disease. Caregivers also experience a substantial humanistic impact, particularly when caring for patients with moderate/severe XLRP.

Conference/Value in Health Info

2023-11, ISPOR Europe 2023, Copenhagen, Denmark

Value in Health, Volume 26, Issue 11, S2 (December 2023)

Code

HSD42

Disease

Rare & Orphan Diseases

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×